Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SIGMAROC PLC Regulatory Filings 2021

Aug 31, 2021

7917_rns_2021-08-31_d5027112-a4e8-4b03-ba79-27f0b4af8906.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 2316K

SigmaRoc PLC

31 August 2021

31 August 2021

(EPIC: SRC / Market: AIM / Sector: Construction Materials)

SIGMAROC PLC

('SigmaRoc' or the 'Company')

Change of Registered Office and Investor Relations Appointment

SigmaRoc, the AIM quoted buy-and-build construction materials group, is pleased to announce that it has changed its registered office to Suite 1, 15 Ingestre Place, London, W1F 0DU with immediate effect. 

As previously notified, Dean Masefield has stepped down from the board of directors and resumed the role that he previously held, Deputy Chief Financial Officer for the PPG, Channel Islands, South Wales and Benelux platforms. In addition, Dean has assumed the role of Head of Investor Relations.

For further information, please contact:

SigmaRoc plc

Max Vermorken
Tel: +44 (0) 207 002 1080
Strand Hanson Limited (Nominated and Financial Adviser)

James Spinney / James Dance / Rob Patrick
Tel: +44(0) 207 409 3494
Liberum Capital (Co-Broker)

Neil Patel / Jamie Richards / William Hall
Tel: +44 (0) 203 100 2000
Peel Hunt (Co-Broker)

Mike Bell / Ed Allsopp
Tel: +44 (0) 20 7418 8900
Investor Relations

Dean Masefield / Florian Werner
Tel: +44 (0) 207 002 1080

[email protected]

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

CROWPUAWRUPGGUG